oxycodone has been researched along with Pain, Chronic in 152 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 128 (84.21) | 24.3611 |
| 2020's | 24 (15.79) | 2.80 |
| Authors | Studies |
|---|---|
| Chu, CC; Chu, LL; Chu, YR; Ho, CH; Teng, SF; Wang, JJ | 1 |
| Druid, H; Jakobsson, G; Kosek, E; Nikosjkov, A; Palada, V; Radoi, V; Terenius, L; Vukojević, V | 1 |
| Barrachina, J; Inda, MD; López-Gil, S; López-Gil, V; Margarit, C; Morales, D; Muriel, J; Peiró, AM; Planelles, B; Vara-González, A | 1 |
| Chandra, R; Dietz, DM; Li, JX; Lobo, MK; Martin, JA; Mitra, S; Sim, FJ; Thomas, SA; Williams, J; Woodhouse, K | 1 |
| Patel, KV; Sahni, S; Taylor, LF | 1 |
| Del Balzo, G; Donadello, K; Gottin, L; Marinangeli, F; Martini, A; Nizzero, M; Polati, E; Rama, J; Schweiger, V; Secchettin, E; Varrassi, G; Vittori, A | 1 |
| Berger, M; Hosseinzadeh, A; Krassioukov, A; Maharaj, A; Rizzardo, A; Sachdeva, R | 1 |
| Dahan, A; Kramers, C; Niesters, M; Olofsen, E; Schellekens, A; van Dam, CJ; van Velzen, M | 1 |
| Chidambaran, V; Dawson, DB; Glauser, TA; Prows, CA; Quinn, CT; Ramsey, LB; Sadhasivam, S; Tang Girdwood, S; Teusink-Cross, A; Vinks, AA | 1 |
| Acharya, M; Dayer, L; Hayes, CJ; Li, C; Martin, BC; Painter, JT | 1 |
| Bass, A; Pixton, GC; Rauck, RL; Wilson, JG; Wolfram, G | 1 |
| Hu, C; Luo, Z; Miao, J; Shen, Y; Shu, S; Wang, Y; Zhu, X | 1 |
| Häuser, W; Klose, P; Petzke, F; Sommer, C; Welsch, P | 1 |
| Bereznicki, L; Boyles, P; Halliday, S; Huckerby, E; Orlikowski, C; Thompson, A; Veal, F | 1 |
| Calderini, E; Egan, CG; Iorno, V; Landi, L; Porro, GA | 1 |
| Chen, G; Hopp, M; Huang, M; Huang, Y; Leng, X; Lu, G; Lu, K; Weng, X; Yao, S; Zeng, X; Zhang, F | 1 |
| LeClair, C; McDonald, JV; Meyer, A | 1 |
| Becker, WC; Edens, EL; Frank, JW | 1 |
| Gazelka, H; Geyer, HL; Mesa, R | 1 |
| Buchbinder, R; Lin, CC; Maher, CG; Mathieson, S; McLachlan, AJ; Pearson, SA; Underwood, M; Wertheimer, G | 1 |
| Comelon, M; Drægni, T; Lenz, H; Lieng, M; Raeder, J | 1 |
| Nakagawa, T | 1 |
| Argoff, CE; Bilker, WB; Cochetti, PT; Farrar, JT; Gilron, I; Haythornthwaite, J; Katz, NP | 1 |
| Hall, C; Hotham, E; Lloyd, RA; Suppiah, V; Williams, M | 1 |
| He, E; Kowalski, M; Pergolizzi, J | 1 |
| Amato, F; Ceniti, S; Consoletti, L; Magaldi, D; Mameli, S; Marcassa, C; Notaro, P; Palmieri, V; Pisanu, GM; Vellucci, R | 1 |
| Lange, B; Serrie, A; Steup, A | 1 |
| Dubois, C; Elling, C; Lange, B; von Zabern, D | 1 |
| Bosse, B; Dupoiron, D; Ellery, A; Hopp, M; Kremers, W; Loewenstein, O; Stachowiak, A | 1 |
| Bai, YJ; Huang, L; Jin, SH; Li, XJ; Liu, DH; Lv, SP; Ma, H; Wang, F; Wang, Y; Zhang, Y; Zhou, JG | 1 |
| Benevento, F; Bolondi, L; Brandi, G; De Lorenzo, S; Piscaglia, F; Samolsky Dekel, BG; Tovoli, F | 1 |
| Huygen, F; Koopmans-Klein, G; Mancini, I; Prenen, H; van Megen, Y; Van Op den Bosch, J | 1 |
| Lucas, CJ; Martin, JH; Patel, J | 1 |
| Kim, ES | 1 |
| Cicero, TJ; Dart, RC; Green, JL; Kurtz, SP; Parrino, MW; Severtson, SG; Vosburg, SK | 1 |
| Caetano, P; Gomes, T; Henry, D; Jain, S; Paterson, JM; Sketris, I | 1 |
| Halalau, A; Said, A | 1 |
| Visconti, A | 1 |
| de C Williams, AC; Donaldson, LJ; Mordecai, L; Reynolds, C | 1 |
| Marom, E; Ponizovsky, AM; Schwartzberg, E; Weizman, A | 1 |
| Bayer, O; Heid, F; Laufenberg-Feldmann, R; Schuster, M | 1 |
| Ahn, JS; Cho, KJ; Chung, SS; Hwang, CJ; Kim, DS; Kim, JH; Lee, JH; Lee, KY; Moon, SH; Park, HJ; Park, YS | 1 |
| Chung, CP; Dupont, WD; Hall, K; Murray, KT; Ray, WA; Stein, CM | 1 |
| Ardid, D; Authier, N; Chenaf, C; Delage, N; Delorme, J; Eschalier, A; Kaboré, JL; Mulliez, A; Pereira, B; Zenut, M | 1 |
| Barnett, ML; Ishisaka, D; Jena, AB; Mehrotra, A; Olenski, AR; Thygeson, NM; Wong, S | 1 |
| Elling, C; Lange, B; Sohns, M; Tempero, J | 1 |
| Buckley, NA; Degenhardt, L; Karanges, EA; Larance, B; Pearson, SA; Schaffer, AL; Wilson, A | 1 |
| Leppert, W; Wordliczek, J; Zajaczkowska, R | 1 |
| Alpert, A; Pacula, RL; Powell, D | 1 |
| Baxter, G; Currie, C; Jenkins-Jones, S; Morgan, CL | 1 |
| Buhidma, Y; Duty, S; Leta, V; Malcangio, M; Ray Chaudhuri, K; Rukavina, K; Sportelli, C | 1 |
| Ball, JB; Fabisiak, T; Grace, PM; Green-Fulgham, SM; Kwilasz, AJ; Maier, SF; Watkins, LR | 1 |
| Dasgupta, N; Jonsson Funk, M; Young, JC | 1 |
| Falke, D; Gálvez, R; Hans, G; Schäfer, M; Steigerwald, I | 1 |
| Duff, S; Gricar, J; Howe, A; Merchant, S; Mody, SH; Noe, LL; Ogden, K | 1 |
| Coleman, J; Kirsh, K; Peppin, J | 1 |
| Cohen, J; Comer, SD; Cooper, ZD; Fugon, L; Jones, JD; Manubay, JM; Mogali, S; Roux, P; Sullivan, MA; Vosburg, SK | 1 |
| Earl, CQ; Narayana, A; Slevin, KA; Webster, LR; Yang, R | 1 |
| Boston, RC; Daly, D; Linares, OA; Stefanovski, D | 1 |
| Meyer, CR | 1 |
| Fujita, M; Hasegawa, M; Hongo, Y; Kanbara, T; Kato, A; Mori, T; Morioka, Y; Nakamura, A; Nishiyori, A; Ogawa, K; Ono, H; Sakaguchi, G; Shibasaki, M; Suzuki, T | 1 |
| Bradshaw, DH; Chapman, CR | 1 |
| Connola, M; Cuomo, A; Esposito, G; Forte, CA; Marcassa, C; Russo, G | 1 |
| Burness, CB; Keating, GM | 1 |
| Boston, RC; Daly, D; Linares, AD; Linares, OA; Stefanovski, D | 1 |
| Coluzzi, F; Ruggeri, M | 3 |
| Narayana, A; Passik, SD; Yang, R | 1 |
| Ben-Joseph, R; Birnbaum, HG; Kirson, NY; Michna, E; Shei, A | 1 |
| Choi, J; Gill, R; Graham, DJ; Kelman, JA; Kropp, GF; MaCurdy, TE; Racoosin, JA; Willy, ME; Worrall, C; Yang, J; Young, J | 1 |
| Huygen, FJ; Koopmans-Klein, G; van Dongen, VC; van Megen, YJ; Van Zundert, J; Vanelderen, PJ | 1 |
| Etropolski, M; Flügel, M; Häufel, T; Kuperwasser, B; Lange, B; Laschewski, F; Rauschkolb, C | 1 |
| Janecki, M; Lux, EA; Maritz, MA | 1 |
| Gatta, L; Scarpignato, C | 1 |
| Ahmedzai, SH; Duerr, H; Hopp, M; Janecki, M; Leppert, W; Lomax, M; Pakosz, A | 1 |
| De Andrés, J; Koopmans, G; Lux, EA; Simpson, K; Van Megen, Y; Wagemans, M | 1 |
| Bednarova, R; Della Rocca, G; Marcassa, C; Miceli, L; Rizzardo, A | 1 |
| Blagden, M; Bosse, B; Duerr, H; Hafer, J; Hopp, M | 1 |
| Kern, KU; Krings, D; Waldmann-Rex, S | 1 |
| Clemens, KE; Dunlop, W; Morlion, B | 1 |
| Bernardy, K; Häuser, W; Maier, C | 1 |
| Guerriero, F; Marcassa, C; Ricevuti, G; Rollone, M; Sgarlata, C | 1 |
| Dickerson, S; Junor, R; Kumar Bhutani, M; Thakur, D | 1 |
| Carlson, DR; Fleming, AB; Grima, M; Kopecky, EA; Mayock, SP; Saim, S; Varanasi, RK | 1 |
| Pergolizzi, JV; Raffa, RB; Taylor, R; Zampogna, G | 1 |
| Kohan, LR; Tran, BW; Vorenkamp, KE | 1 |
| Dioh, A; Gorissen, M; Koopmans-Klein, G; Logé, D; Louis, F; Poelaert, J; van Megen, YJ; Van Op den Bosch, J | 1 |
| Duse, G; Ferrari, R; Visentin, M; Zanolin, ME | 1 |
| Plotzker, DA | 1 |
| Bass, A; Bramson, C; Hale, ME; Malhotra, BK; Meisner, P; Pixton, G; Rauck, RL; Setnik, B; Sommerville, KW; Wilson, JG; Wolfram, G | 1 |
| Alarcão, J; Costa, J; Fareleira, F; Santos, J; Vaz-Carneiro, A | 1 |
| Ando, Y; Gyawali, B; Hayashi, N; Honda, K; Shimokata, T; Tsukuura, H | 1 |
| Dauri, M; Madeo, G; Natoli, S; Pierantozzi, M; Pisani, A; Schirinzi, T; Stefani, A | 1 |
| Barrett, T; Devarakonda, K; Eisenhauer, TD; Giuliani, M; Heasley, R; Matchett, M; Morton, T; Young, JL | 1 |
| Fanelli, A; Fanelli, G | 1 |
| Brown, RH; Fleming, AB; Katz, N; Kopecky, EA; O'Connor, M | 1 |
| Francis, M; Guerriero, F; Maurizi, N; Perna, S; Ricevuti, G; Rollone, M; Rondanelli, M; Sgarlata, C | 1 |
| Arendt-Nielsen, L; Curatolo, M; Juni, P; Schliessbach, J; Siegenthaler, A; Vuilleumier, PH; Zeilhofer, HU | 1 |
| Arsenault, P; Buynak, R; Etropolski, M; Heisig, F; Rappaport, SA; Rauschkolb, C; Rod, K | 1 |
| Goeree, J; Goeree, R | 1 |
| Caldarulo, C; Corli, O; Finocchi, S; Greco, MT; Lazzari, M; Marcassa, C | 1 |
| Mccarberg, B | 1 |
| Berlin, J | 1 |
| Kraus, S | 1 |
| Crotti, C; Ingegnoli, F; Ughi, N | 1 |
| Corli, O; Greco, MT; Guerriero, F; Roberto, A; Rollone, M; Sgarlata, C | 1 |
| Bennett, CL; Chen, B; Yang, YT | 1 |
| Davis, MP | 1 |
| Caldarulo, C; Carpenedo, R; Dauri, M; Lazzari, M; Marcassa, C; Natoli, S; Silvi, MB | 1 |
| Chung, CP; Hall, K; Murray, KT; Ray, WA; Stein, CM | 1 |
| Gurwitz, JH; Hume, AL; Lapane, KL; Pimentel, CB; Tjia, J | 1 |
| Carpenter, DM; Rubinstein, AL | 1 |
| Chilcoat, HD; Coplan, PM; Green, CA; Janoff, SL; McCarty, D; Stumbo, SP; Yarborough, BJ; Yarborough, MT | 1 |
| Bertholf, RL; Reisfield, GM; Sharma, R | 1 |
| Cavallari, G; Croci Chiocchini, AL; Di Nino, G; Donati, G; Gori, A; La Manna, G; Mandrioli, R; Melotti, RM; Mercolini, L; Protti, M; Samolsky Dekel, BG; Vasarri, A | 1 |
| Fleming, AB; Kopecky, EA; Marseilles, A; McCarberg, BH; O'Connor, M; Thompson, C; Varanasi, RK | 1 |
| Garnock-Jones, KP; Keam, SJ; Lamb, YN | 1 |
| Gajria, KL; Harshaw, Q; Katz, NP; Shillington, AC; Stephenson, JJ | 1 |
| Becker, WC; Edens, EL; Guillod, P | 1 |
| Anderson, EM; Avrampou, K; Carr, FB; Cogliani, V; Gaspari, S; Manouras, L; Mitsi, V; Zachariou, V | 1 |
| Barth, KS; Brady, KT; Guille, C; Mateus, J; McCauley, JL | 1 |
| Chang, F; Ibrahim, S | 1 |
| Mercadante, S | 1 |
| Aragaki, D; Baria, A; Bolus, R; Davis, F; Naliboff, BD; Pham, Q; Schieffer, B; Shekelle, P; Van Vort, W; Wu, SM | 1 |
| Hagelberg, NM; Laine, K; Neuvonen, M; Neuvonen, PJ; Nieminen, TH; Olkkola, KT; Saari, TI | 1 |
| Chiba, S; Hara, A; Homma, M; Kohda, Y; Momo, K; Okoshi, Y; Wada, T; Watanabe, M | 1 |
| Clemens, KE; Klaschik, E; Quednau, I | 1 |
| Cepeda, MS; Kim, M; Sutton, A; Weinstein, R | 1 |
| Andreassen, TN; Bjordal, K; Dale, O; Davies, A; Eftedal, I; Kaasa, S; Klepstad, P; Lundström, S | 1 |
| Hale, M; Landau, C; Munera, C; Ripa, S; Steiner, D | 1 |
| Ahmedzai, SH; Bar-Sela, G; Bosse, B; Hopp, M; Leyendecker, P; Nauck, F | 1 |
| Patel, TA; Rastogi, R; Swarm, RA | 1 |
| Abrams, DI; Benowitz, NL; Couey, P; Kelly, ME; Shade, SB | 1 |
| Kahan, M; Mailis-Gagnon, A; Srivastava, A; Wilson, L | 1 |
| Boisvert, L; Copeland, J; Osmun, WE; Parr, J | 1 |
| Janecek, E; Kahan, M; Resnick, A; Sheehan, C; Srivastava, A; Wenghofer, EF; Wilson, L | 1 |
| Ware, MA | 1 |
| Hermanns, K; Junker, U; Nolte, T | 1 |
| Baxter, G; Conway, P; Hertel, N; Ikenberg, R; Liedgens, H; Moore, RA; Obradovic, M | 1 |
| Binsfeld, H; Richarz, U; Sabatowski, R; Szczepanski, L; Waechter, S | 1 |
| Chen, BC; Hoffman, RS | 1 |
| Godfrey, A | 1 |
| Benson, C; Biondi, D; Chang, H; Chow, W; Kim, MS; Lerner, D; Rogers, WH | 1 |
| Viswesh, VV | 1 |
| Gregory, TB | 1 |
| Pappagallo, M; Sokolowska, M | 1 |
| Ackerman, SJ; Anastassopoulos, KP; Baik, R; Biondi, D; Chow, W; Kim, MS; Tapia, CI | 1 |
| Giarratano, A; Mercadante, S | 1 |
| Merchant, S; Mody, SH; Neil, N; Ogden, K; Provenzano, D | 1 |
| Casali, M; Gafforio, P; Gatti, A; Lazzari, M; Marcassa, C; Sabato, AF; Silvestri, C; Tufaro, G | 1 |
| Gossrau, G; Heineck, R; Kaiser, U; Sabatowski, R; Scharnagel, R; Schütze, A | 1 |
30 review(s) available for oxycodone and Pain, Chronic
| Article | Year |
|---|---|
Opioids for chronic non-cancer neuropathic pain. An updated systematic review and meta-analysis of efficacy, tolerability and safety in randomized placebo-controlled studies of at least 4 weeks duration.
Topics: Analgesics, Opioid; Chronic Pain; Humans; Morphine; Neuralgia; Oxycodone; Tapentadol | 2020 |
The Prevalence of Opioid Analgesic Use in People with Chronic Noncancer Pain: Systematic Review and Meta-Analysis of Observational Studies.
Topics: Adult; Analgesics, Opioid; Chronic Pain; Humans; Observational Studies as Topic; Opioid-Related Disorders; Oxycodone; Prevalence | 2021 |
Pharmacogenomics and Patient Treatment Parameters to Opioid Treatment in Chronic Pain: A Focus on Morphine, Oxycodone, Tramadol, and Fentanyl.
Topics: Analgesics, Opioid; Chronic Pain; Fentanyl; Humans; Morphine; Oxycodone; Pharmacogenomic Testing; Pharmacogenomic Variants; Polymorphism, Single Nucleotide; Tramadol | 2017 |
Efficacy and safety of tapentadol prolonged release for moderate-to-severe chronic osteoarthritis knee pain: a pooled analysis of two double-blind, randomized, placebo- and oxycodone controlled release-controlled studies.
Topics: Aged; Chronic Pain; Constipation; Delayed-Action Preparations; Double-Blind Method; Female; Health Status; Humans; Male; Middle Aged; Nausea; Osteoarthritis, Knee; Oxycodone; Phenols; Randomized Controlled Trials as Topic; Tapentadol; Vomiting | 2017 |
Opioid-Induced Constipation Relief From Fixed-Ratio Combination Prolonged-Release Oxycodone/Naloxone Compared With Oxycodone and Morphine for Chronic Nonmalignant Pain: A Systematic Review and Meta-Analysis of Randomized Controlled Trials.
Topics: Analgesics, Opioid; Chronic Pain; Constipation; Delayed-Action Preparations; Drug Combinations; Drug Therapy, Combination; Humans; Morphine; Naloxone; Oxycodone; Randomized Controlled Trials as Topic | 2017 |
Oxycodone/Naloxone Prolonged Release: A Review in Severe Chronic Pain.
Topics: Adult; Analgesics, Opioid; Chronic Pain; Constipation; Delayed-Action Preparations; Diarrhea; Drug Combinations; Gastrointestinal Tract; Humans; Naloxone; Nausea; Neoplasms; Oxycodone | 2017 |
Opioid Rotation in Cancer Pain Treatment.
Topics: Analgesics, Opioid; Buprenorphine; Cancer Pain; Chronic Pain; Fentanyl; Germany; Humans; Hydromorphone; Morphine; Neoplasms; Oxycodone; Pain Management | 2018 |
Efficacy and safety of tapentadol prolonged release formulation in the treatment of elderly patients with moderate-to-severe chronic osteoarthritis knee pain: a pooled analysis of two double-blind, randomized, placebo-, and active-controlled trials.
Topics: Aged; Chronic Pain; Clinical Trials, Phase III as Topic; Constipation; Delayed-Action Preparations; Double-Blind Method; Female; Health Status Indicators; Humans; Male; Middle Aged; Nausea; Osteoarthritis, Knee; Oxycodone; Randomized Controlled Trials as Topic; Tapentadol; Vertigo; Vomiting | 2018 |
The role of oxycodone/naloxone in the management of patients with pain and opioid-induced constipation.
Topics: Analgesics, Opioid; Chronic Pain; Constipation; Delayed-Action Preparations; Drug Combinations; Gastrointestinal Diseases; Humans; Laxatives; Naloxone; Narcotic Antagonists; Oxycodone; Receptors, Opioid; Receptors, Opioid, mu; Tablets | 2019 |
Pain in Parkinson's disease: new concepts in pathogenesis and treatment.
Topics: Analgesics; Botulinum Toxins; Chronic Pain; Deep Brain Stimulation; Duloxetine Hydrochloride; Humans; Naloxone; Oxycodone; Pain Management; Parkinson Disease | 2019 |
Characterization of prescription opioid abuse in the United States: focus on route of administration.
Topics: Administration, Oral; Adolescent; Adult; Analgesics; Child; Chronic Pain; Delayed-Action Preparations; Drug Overdose; Female; Humans; Male; Middle Aged; Opioid-Related Disorders; Oxycodone; Practice Patterns, Physicians'; Risk Assessment; Rural Population; Sex Factors; United States | 2012 |
Oxycodone/Naloxone prolonged-release: a review of its use in the management of chronic pain while counteracting opioid-induced constipation.
Topics: Analgesics, Opioid; Chronic Pain; Constipation; Delayed-Action Preparations; Drug Combinations; Drug Interactions; Humans; Naloxone; Narcotic Antagonists; Opioid-Related Disorders; Oxycodone; Quality of Life | 2014 |
Clinical and economic evaluation of tapentadol extended release and oxycodone/naloxone extended release in comparison with controlled release oxycodone in musculoskeletal pain.
Topics: Chronic Pain; Cost-Benefit Analysis; Delayed-Action Preparations; Humans; Italy; Musculoskeletal Pain; Naloxone; Oxycodone; Phenols; Tapentadol; Treatment Outcome | 2014 |
Safety and tolerability of tapentadol extended release in moderate to severe chronic osteoarthritis or low back pain management: pooled analysis of randomized controlled trials.
Topics: Adult; Aged; Analgesics; Chronic Pain; Delayed-Action Preparations; Double-Blind Method; Drug-Related Side Effects and Adverse Reactions; Female; Humans; Low Back Pain; Male; Middle Aged; Osteoarthritis, Hip; Osteoarthritis, Knee; Oxycodone; Pain Management; Pain Measurement; Phenols; Randomized Controlled Trials as Topic; Receptors, Opioid, mu; Tapentadol; Treatment Outcome | 2014 |
[Clinical and economical evaluation of new analgesics for the management of chronic pain].
Topics: Analgesics, Opioid; Chronic Pain; Cost-Benefit Analysis; Drug Combinations; Drug Costs; Economics, Pharmaceutical; Humans; Models, Economic; Naloxone; Oxycodone; Phenols; Quality of Life; Quality-Adjusted Life Years; Tapentadol | 2014 |
Quality of life and healthcare resource in patients receiving opioids for chronic pain: a review of the place of oxycodone/naloxone.
Topics: Analgesics, Opioid; Animals; Chronic Pain; Constipation; Delayed-Action Preparations; Drug Combinations; Gastrointestinal Diseases; Health Resources; Humans; Naloxone; Narcotic Antagonists; Oxycodone; Quality of Life; Randomized Controlled Trials as Topic | 2015 |
[Long-term opioid therapy in chronic noncancer pain. A systematic review and meta-analysis of efficacy, tolerability and safety in open-label extension trials with study duration of at least 26 weeks].
Topics: Analgesics, Opioid; Buprenorphine; Chronic Pain; Hydromorphone; Long-Term Care; Morphine; Oxycodone; Oxymorphone; Pain Measurement; Phenols; Randomized Controlled Trials as Topic; Tapentadol; Tramadol; Treatment Outcome | 2015 |
Impact of prolonged-release oxycodone/naloxone on outcomes affecting patients' daily functioning in comparison with extended-release tapentadol: a systematic review.
Topics: Chronic Pain; Constipation; Delayed-Action Preparations; Double-Blind Method; Drug Combinations; Headache; Humans; Naloxone; Nausea; Oxycodone; Phenols; Quality of Life; Tapentadol; Vomiting | 2015 |
Long-term efficacy, safety and tolerability of Remoxy for the management of chronic pain.
Topics: Analgesics, Opioid; Chronic Pain; Delayed-Action Preparations; Disease Management; Humans; Oxycodone; Treatment Outcome | 2015 |
Tapentadol for chronic musculoskeletal pain in adults.
Topics: Adult; Analgesics, Opioid; Chronic Pain; Clinical Trials, Phase III as Topic; Humans; Low Back Pain; Musculoskeletal Pain; Osteoarthritis, Knee; Oxycodone; Phenols; Randomized Controlled Trials as Topic; Tapentadol | 2015 |
Opioid-induced constipation.
Topics: Chloride Channel Agonists; Chronic Pain; Constipation; Humans; Laxatives; Lubiprostone; Naloxone; Oxycodone; Peptides; Phenols; Receptors, Opioid, mu; Tapentadol | 2015 |
Developments in managing severe chronic pain: role of oxycodone-naloxone extended release.
Topics: Analgesics, Opioid; Chronic Pain; Constipation; Delayed-Action Preparations; Drug Combinations; Humans; Naloxone; Narcotic Antagonists; Oxycodone; Quality of Life; Severity of Illness Index | 2015 |
Pharmacokinetic and pharmacodynamic evaluation of oxycodone and naltrexone for the treatment of chronic lower back pain.
Topics: Analgesics, Opioid; Animals; Chronic Pain; Delayed-Action Preparations; Drug Combinations; Humans; Low Back Pain; Naltrexone; Opioid-Related Disorders; Oxycodone; Practice Guidelines as Topic | 2016 |
An abuse-deterrent, microsphere-in-capsule formulation of extended-release oxycodone: alternative modes of administration to facilitate pain management in patients with dysphagia.
Topics: Administration, Oral; Analgesics, Opioid; Chronic Pain; Clinical Trials as Topic; Deglutition Disorders; Humans; Oxycodone; Pain Management | 2016 |
Oxycodone DETERx
Topics: Analgesics, Opioid; Capsules; Chemistry, Pharmaceutical; Chronic Pain; Clinical Trials, Phase III as Topic; Delayed-Action Preparations; Humans; Oxycodone | 2016 |
Oxycodone extended release capsules for the treatment of chronic pain.
Topics: Analgesics, Opioid; Capsules; Child; Chronic Pain; Delayed-Action Preparations; Humans; Oxycodone | 2017 |
Case scenario: opioid association with serotonin syndrome: implications to the practitioners.
Topics: Analgesics, Opioid; Antidepressive Agents, Tricyclic; Celecoxib; Chronic Pain; Cyclooxygenase 2 Inhibitors; Depressive Disorder; Desipramine; Drug Interactions; Duloxetine Hydrochloride; Fentanyl; Humans; Male; Methadone; Middle Aged; Oxycodone; Polypharmacy; Pyrazoles; Selective Serotonin Reuptake Inhibitors; Serotonin Syndrome; Sulfonamides; Thiophenes; Transdermal Patch | 2011 |
Chronic pain perspectives: Sickle cell disease: Gaining control over the pain.
Topics: Adaptation, Psychological; Adult; Analgesia, Patient-Controlled; Analgesics, Opioid; Anemia, Sickle Cell; Chronic Pain; Disease Progression; Female; Humans; Hydroxyurea; Life Style; Oxycodone | 2012 |
Combined oral prolonged-release oxycodone and naloxone in chronic pain management.
Topics: Analgesics, Opioid; Chronic Pain; Delayed-Action Preparations; Drug Combinations; Humans; Naloxone; Oxycodone; Treatment Outcome | 2013 |
[Chronic non-cancer-related pain. Long-term treatment with rapid-release and short-acting opioids in the context of misuse and dependency].
Topics: Abdominal Pain; Adult; Analgesics, Opioid; Chronic Pain; Diabetic Neuropathies; Dose-Response Relationship, Drug; Drug Administration Schedule; Drug Utilization; Female; Fentanyl; Guideline Adherence; Headache Disorders; Humans; Long-Term Care; Male; Middle Aged; Opioid-Related Disorders; Oxycodone; Physician-Patient Relations; Practice Patterns, Physicians'; Prescription Drug Misuse; Risk Factors; Tilidine | 2013 |
32 trial(s) available for oxycodone and Pain, Chronic
| Article | Year |
|---|---|
Cannabis-opioid interaction in the treatment of fibromyalgia pain: an open-label, proof of concept study with randomization between treatment groups: cannabis, oxycodone or cannabis/oxycodone combination-the SPIRAL study.
Topics: Analgesics, Opioid; Cannabis; Chronic Pain; Delayed-Action Preparations; Fibromyalgia; Humans; Oxycodone; Pharmaceutical Preparations; Proof of Concept Study; Random Allocation | 2023 |
Pharmacokinetics and Bioequivalence Evaluation of a New Oxycodone Tamper-Resistant Tablet Administered with an Opioid Antagonist in Patients with Chronic Pain.
Topics: Adult; Analgesics, Opioid; Chronic Pain; Cross-Over Studies; Delayed-Action Preparations; Fasting; Female; Humans; Male; Middle Aged; Naltrexone; Narcotic Antagonists; Oxycodone; Tablets; Therapeutic Equivalency | 2020 |
Long-term effect of oxycodone/naloxone on the management of postoperative pain after hysterectomy: a randomized prospective study.
Topics: Analgesics, Opioid; Chronic Pain; Constipation; Delayed-Action Preparations; Drug Combinations; Female; Humans; Hysterectomy; Naloxone; Oxycodone; Pain, Postoperative; Prospective Studies | 2020 |
Prolonged-Release (PR) Oxycodone/Naloxone Improves Bowel Function Compared with Oxycodone PR and Provides Effective Analgesia in Chinese Patients with Non-malignant Pain: A Randomized, Double-Blind Trial.
Topics: Aged; Aged, 80 and over; Analgesics; Analgesics, Opioid; China; Chronic Pain; Delayed-Action Preparations; Double-Blind Method; Drug Combinations; Female; Humans; Laxatives; Male; Middle Aged; Naloxone; Opioid-Induced Constipation; Oxycodone; Pain Management; Quality of Life | 2020 |
Tapentadol versus oxycodone analgesia and side effects after laparoscopic hysterectomy: A randomised controlled trial.
Topics: Analgesia; Analgesics, Opioid; Chronic Pain; Double-Blind Method; Female; Humans; Hysterectomy; Laparoscopy; Oxycodone; Pain, Postoperative; Phenols; Tapentadol | 2021 |
High dosage of a fixed combination oxycodone/naloxone prolonged release: efficacy and tolerability in patients with chronic cancer pain.
Topics: Adult; Aged; Aged, 80 and over; Analgesics; Breakthrough Pain; Cancer Pain; Chronic Pain; Constipation; Delayed-Action Preparations; Dose-Response Relationship, Drug; Drug Combinations; Female; Humans; Laxatives; Male; Middle Aged; Naloxone; Neoplasms; Oxycodone; Pain Management; Pain Measurement; Quality of Life | 2017 |
Tapentadol prolonged-release for moderate-to-severe chronic osteoarthritis knee pain: a double-blind, randomized, placebo- and oxycodone controlled release-controlled study.
Topics: Aged; Chronic Pain; Constipation; Delayed-Action Preparations; Double-Blind Method; Female; Health Status; Humans; Male; Middle Aged; Nausea; Osteoarthritis, Knee; Oxycodone; Phenols; Tapentadol; Vomiting | 2017 |
A phase III randomized controlled study on the efficacy and improved bowel function of prolonged-release (PR) oxycodone-naloxone (up to 160/80 mg daily) vs oxycodone PR.
Topics: Adult; Aged; Aged, 80 and over; Analgesics, Opioid; Chronic Pain; Constipation; Delayed-Action Preparations; Double-Blind Method; Drug Combinations; Female; Humans; Male; Middle Aged; Naloxone; Oxycodone; Pain Management; Treatment Outcome; Young Adult | 2017 |
Prolonged release oxycodone and naloxone treatment counteracts opioid-induced constipation in patients with severe pain compared to previous analgesic treatment.
Topics: Aged; Analgesics, Opioid; Chronic Pain; Constipation; Defecation; Delayed-Action Preparations; Drug Combinations; Female; Humans; Laxatives; Male; Middle Aged; Naloxone; Oxycodone; Prospective Studies; Quality of Life | 2017 |
Analgesic Efficacy and Safety of Prolonged-Release Oxycodone/Naloxone in Korean Patients with Chronic Pain from Spinal Disorders.
Topics: Aged; Analgesics, Opioid; Back Pain; Chronic Pain; Constipation; Delayed-Action Preparations; Dizziness; Drug Combinations; Female; Humans; Intention to Treat Analysis; Male; Middle Aged; Naloxone; Nausea; Oxycodone; Pain Measurement; Quality of Life; Republic of Korea; Severity of Illness Index; Spinal Diseases | 2018 |
Tapentadol prolonged release versus strong opioids for severe, chronic low back pain: results of an open-label, phase 3b study.
Topics: Adult; Aged; Analgesics, Opioid; Buprenorphine; Chronic Pain; Constipation; Delayed-Action Preparations; Female; Fentanyl; Humans; Hydromorphone; Low Back Pain; Male; Middle Aged; Morphine; Neuralgia; Oxycodone; Pain Measurement; Phenols; Severity of Illness Index; Tapentadol | 2013 |
Fentanyl buccal tablet compared with immediate-release oxycodone for the management of breakthrough pain in opioid-tolerant patients with chronic cancer and noncancer pain: a randomized, double-blind, crossover study followed by a 12-week open-label phase
Topics: Administration, Buccal; Adolescent; Adult; Aged; Aged, 80 and over; Analgesics; Breakthrough Pain; Chronic Pain; Cross-Over Studies; Double-Blind Method; Female; Fentanyl; Humans; Male; Middle Aged; Neoplasms; Oxycodone; Pain Management; Patient Satisfaction; Treatment Outcome; Young Adult | 2013 |
A new model for using quantitative urine testing as a diagnostic tool for oxycodone treatment and compliance.
Topics: Administration, Oral; Adult; Aged; Analgesics, Opioid; Black or African American; Chronic Pain; Cross-Sectional Studies; Dose-Response Relationship, Drug; Female; Humans; Male; Medication Adherence; Middle Aged; Models, Biological; Oxycodone; Pain Measurement; Prospective Studies; White People | 2013 |
Personalized oxycodone dosing: using pharmacogenetic testing and clinical pharmacokinetics to reduce toxicity risk and increase effectiveness.
Topics: Adult; Algorithms; Analgesics, Opioid; Chronic Pain; Cross-Over Studies; Cytochrome P-450 CYP2D6; Double-Blind Method; Genotype; Humans; Male; Models, Biological; Nonlinear Dynamics; Oxycodone; Pain, Postoperative; Pharmacogenetics; Phenotype; Precision Medicine; Risk | 2014 |
Aberrant drug-related behavior observed during a 12-week open-label extension period of a study involving patients taking chronic opioid therapy for persistent pain and fentanyl buccal tablet or traditional short-acting opioid for breakthrough pain.
Topics: Administration, Buccal; Analgesics, Opioid; Breakthrough Pain; Chronic Pain; Cross-Over Studies; Dosage Forms; Double-Blind Method; Female; Fentanyl; Humans; Male; Middle Aged; Opioid-Related Disorders; Oxycodone; Tablets | 2014 |
Patient preference with respect to QoL and reduction in opioid-induced constipation (OIC) after treatment with prolonged-release (PR) oxycodone/naloxone compared with previous analgesic therapy [PREFER study].
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Analgesics, Opioid; Chronic Pain; Constipation; Drug Combinations; Female; Humans; Male; Middle Aged; Naloxone; Opioid-Related Disorders; Oxycodone; Patient Preference; Quality of Life | 2014 |
Clinical evaluation of the first oxycodone once daily prolonged release tablet in moderate to severe chronic pain: a randomized, double-blind, multicenter, cross-over, non-inferiority study to investigate efficacy and safety in comparison with an establis
Topics: Adult; Aged; Analgesics, Opioid; Chronic Pain; Cross-Over Studies; Delayed-Action Preparations; Double-Blind Method; Drug Administration Schedule; Female; Humans; Male; Middle Aged; Oxycodone; Pain Measurement; Prospective Studies; Tablets; Treatment Outcome | 2014 |
Long-term safety and efficacy of oxycodone/naloxone prolonged-release tablets in patients with moderate-to-severe chronic cancer pain.
Topics: Aged; Analgesics, Opioid; Chronic Pain; Constipation; Delayed-Action Preparations; Double-Blind Method; Drug Combinations; Female; Follow-Up Studies; Humans; Male; Middle Aged; Naloxone; Neoplasms; Oxycodone; Pain Management; Pain Measurement; Quality of Life; Severity of Illness Index; Tablets; Treatment Outcome | 2015 |
Fixed ratio (2:1) prolonged-release oxycodone/naloxone combination improves bowel function in patients with moderate-to-severe pain and opioid-induced constipation refractory to at least two classes of laxatives.
Topics: Adult; Aged; Aged, 80 and over; Analgesics, Opioid; Chronic Pain; Constipation; Defecation; Delayed-Action Preparations; Double-Blind Method; Drug Combinations; Female; Humans; Laxatives; Male; Middle Aged; Naloxone; Neoplasms; Oxycodone; Treatment Outcome | 2014 |
Long-term evaluation of combined prolonged-release oxycodone and naloxone in patients with moderate-to-severe chronic pain: pooled analysis of extension phases of two Phase III trials.
Topics: Adult; Aged; Aged, 80 and over; Analgesics; Chronic Pain; Constipation; Delayed-Action Preparations; Double-Blind Method; Drug Combinations; Female; Humans; Male; Middle Aged; Naloxone; Oxycodone; Surveys and Questionnaires | 2014 |
[Tapentadol prolonged release improves analgesia, functional impairment and quality of life in patients with chronic pain who have previously received oxycodone/naloxone].
Topics: Activities of Daily Living; Adult; Aged; Aged, 80 and over; Back Pain; Chronic Pain; Delayed-Action Preparations; Dose-Response Relationship, Drug; Drug Administration Schedule; Drug Combinations; Drug Substitution; Female; Germany; Humans; Male; Middle Aged; Naloxone; Oxycodone; Pain Measurement; Patient Satisfaction; Phenols; Prospective Studies; Quality of Life; Tapentadol | 2014 |
A randomized double-blind, placebo-controlled efficacy and safety study of ALO-02 (extended-release oxycodone surrounding sequestered naltrexone) for moderate-to-severe chronic low back pain treatment.
Topics: Adult; Aged; Aged, 80 and over; Analgesics, Opioid; Analysis of Variance; Chronic Pain; Delayed-Action Preparations; Dose-Response Relationship, Drug; Double-Blind Method; Drug Combinations; Humans; Low Back Pain; Middle Aged; Naltrexone; Narcotic Antagonists; Oxycodone; Pain Measurement; Treatment Outcome; Young Adult | 2015 |
A phase 3, multicenter, randomized, double-blind, placebo-controlled, safety, tolerability, and efficacy study of Xtampza ER in patients with moderate-to-severe chronic low back pain.
Topics: Adult; Analgesics, Opioid; Chronic Pain; Delayed-Action Preparations; Double-Blind Method; Female; Humans; Low Back Pain; Male; Middle Aged; Oxycodone; Pain Measurement; Severity of Illness Index; Treatment Outcome | 2015 |
Linking altered central pain processing and genetic polymorphism to drug efficacy in chronic low back pain.
Topics: Adolescent; Adult; Aged; Analgesics; Benzodiazepines; Chronic Pain; Clinical Protocols; Clobazam; Cross-Over Studies; Double-Blind Method; Female; Humans; Imipramine; Low Back Pain; Male; Middle Aged; Oxycodone; Pain Measurement; Polymorphism, Genetic; Young Adult | 2015 |
Long-term Safety and Efficacy of Tapentadol Extended Release Following up to 2 Years of Treatment in Patients With Moderate to Severe, Chronic Pain: Results of an Open-label Extension Trial.
Topics: Aged; Chronic Disease; Chronic Pain; Cross-Over Studies; Delayed-Action Preparations; Female; Humans; Low Back Pain; Male; Middle Aged; Osteoarthritis, Knee; Oxycodone; Phenols; Quality of Life; Tapentadol | 2015 |
A randomized trial of 2 prescription strategies for opioid treatment of chronic nonmalignant pain.
Topics: Aged; Analgesia; Analgesics, Opioid; Chronic Pain; Codeine; Dose-Response Relationship, Drug; Drug Therapy, Combination; Female; Humans; Hydrocodone; Male; Middle Aged; Morphine; Musculoskeletal Diseases; Oxycodone; Pain Measurement | 2011 |
Bowel function during pain therapy with oxycodone/naloxone prolonged-release tablets in patients with advanced cancer.
Topics: Aged; Aged, 80 and over; Analgesics, Opioid; Chronic Pain; Constipation; Delayed-Action Preparations; Drug Combinations; Female; Humans; Male; Middle Aged; Naloxone; Neoplasms; Oxycodone; Tablets | 2011 |
Efficacy and safety of buprenorphine transdermal system (BTDS) for chronic moderate to severe low back pain: a randomized, double-blind study.
Topics: Administration, Cutaneous; Analgesics, Opioid; Buprenorphine; Chronic Pain; Double-Blind Method; Female; Humans; Low Back Pain; Male; Middle Aged; Oxycodone; Transdermal Patch; Treatment Outcome | 2011 |
A randomized, double-blind, active-controlled, double-dummy, parallel-group study to determine the safety and efficacy of oxycodone/naloxone prolonged-release tablets in patients with moderate/severe, chronic cancer pain.
Topics: Adult; Aged; Aged, 80 and over; Analgesics, Opioid; Chronic Pain; Constipation; Delayed-Action Preparations; Double-Blind Method; Drug Therapy, Combination; Female; Humans; Male; Middle Aged; Naloxone; Neoplasms; Oxycodone; Quality of Life | 2012 |
Cannabinoid-opioid interaction in chronic pain.
Topics: Administration, Inhalation; Adult; Analgesics, Opioid; Area Under Curve; Chronic Pain; Delayed-Action Preparations; Dronabinol; Drug Administration Schedule; Drug Synergism; Female; Humans; Male; Middle Aged; Morphine; Oxycodone; Treatment Outcome | 2011 |
Sustained safety and efficacy of once-daily hydromorphone extended-release (OROS® hydromorphone ER) compared with twice-daily oxycodone controlled-release over 52 weeks in patients with moderate to severe chronic noncancer pain.
Topics: Adult; Aged; Aged, 80 and over; Analgesics, Opioid; Chronic Pain; Drug Administration Schedule; Drug Delivery Systems; Emotions; Female; Follow-Up Studies; Humans; Hydromorphone; Male; Middle Aged; Oxycodone; Pain Measurement; Quality of Life; Sleep Wake Disorders; Time Factors; Treatment Outcome | 2013 |
Imputing at-work productivity loss using results of a randomized controlled trial comparing tapentadol extended release and oxycodone controlled release for osteoarthritis pain.
Topics: Adult; Aged; Analgesics; Chronic Pain; Delayed-Action Preparations; Efficiency; Female; Humans; Male; Middle Aged; Osteoarthritis, Knee; Oxycodone; Phenols; Severity of Illness Index; Tapentadol | 2012 |
90 other study(ies) available for oxycodone and Pain, Chronic
| Article | Year |
|---|---|
Prevalence of opioid prescriptions in Taiwan (2008-2018).
Topics: Analgesics, Opioid; Chronic Pain; Drug Prescriptions; Humans; Meperidine; Morphine; Neoplasms; Oxycodone; Prevalence; Taiwan; United States | 2022 |
Non-Peptide Opioids Differ in Effects on Mu-Opioid (MOP) and Serotonin 1A (5-HT
Topics: Analgesics, Opioid; Chronic Pain; Codeine; Fentanyl; Humans; MAP Kinase Signaling System; Morphine; Oxycodone; Receptor, Serotonin, 5-HT1A; Receptors, Opioid, mu | 2022 |
Oxycodone/naloxone versus tapentadol in real-world chronic non-cancer pain management: an observational and pharmacogenetic study.
Topics: Analgesics, Opioid; Cancer Pain; Chronic Pain; Constipation; Delayed-Action Preparations; Drug Combinations; Female; Humans; Morphine; Naloxone; Oxycodone; Pharmacogenomic Testing; Quality of Life; Tapentadol | 2022 |
EGR3 regulates opioid-related nociception and motivation in male rats.
Topics: Analgesics, Opioid; Animals; Chronic Pain; Early Growth Response Protein 3; Freund's Adjuvant; Male; Motivation; Nociception; Oxycodone; Rats | 2022 |
Successful buprenorphine transition while overlapping with a full opioid agonist to treat chronic pain: a case report.
Topics: Acetaminophen; Analgesics, Opioid; Animals; Breakthrough Pain; Buprenorphine; Cattle; Chronic Pain; Female; Humans; Oxycodone; Quality of Life | 2023 |
Oxycodone-Naloxone Combination Hinders Opioid Consumption in Osteoarthritic Chronic Low Back Pain: A Retrospective Study with Two Years of Follow-Up.
Topics: Analgesics, Opioid; Chronic Pain; Delayed-Action Preparations; Drug Combinations; Drug Tolerance; Follow-Up Studies; Humans; Low Back Pain; Naloxone; Narcotic Antagonists; Oxycodone; Retrospective Studies | 2022 |
No pain, no strain: Targin® mitigates pain and constipation following spinal cord injury.
Topics: Analgesics, Opioid; Autonomic Dysreflexia; Chronic Pain; Constipation; Delayed-Action Preparations; Drug Combinations; Humans; Male; Middle Aged; Naloxone; Narcotic Antagonists; Oxycodone; Spinal Cord Injuries | 2023 |
Implementation of CYP2D6-guided opioid therapy at Cincinnati Children's Hospital Medical Center.
Topics: Analgesics, Opioid; Chronic Pain; Codeine; Cytochrome P-450 CYP2D6; Humans; Oxycodone; Pharmacogenetics; Practice Patterns, Physicians' | 2023 |
Comparative Study of Opioid Initiation With Tramadol, Short-acting Hydrocodone, or Short-acting Oxycodone on Opioid-related Adverse Outcomes Among Chronic Noncancer Pain Patients.
Topics: Analgesics, Opioid; Chronic Pain; Humans; Hydrocodone; Opioid-Related Disorders; Oxycodone; Retrospective Studies; Tramadol | 2023 |
Safety and tolerability of ALO-02 (oxycodone hydrochloride and sequestered naltrexone hydrochloride) extended-release capsules in older patients: a pooled analysis of two clinical trials.
Topics: Adult; Aged; Aged, 80 and over; Analgesics, Opioid; Chronic Pain; Delayed-Action Preparations; Double-Blind Method; Drug Combinations; Female; Humans; Low Back Pain; Male; Middle Aged; Naltrexone; Oxycodone; Randomized Controlled Trials as Topic; Young Adult | 2020 |
Does prescribing of immediate release oxycodone by emergency medicine physicians result in persistence of Schedule 8 opioids following discharge?
Topics: Aged; Analgesics, Opioid; Chronic Pain; Cross-Sectional Studies; Emergency Medicine; Humans; Oxycodone; Patient Discharge; Physicians; Practice Patterns, Physicians'; Retrospective Studies | 2020 |
Prescription Opioid Prescribing in Western Europe and the United States.
Topics: Acute Pain; Analgesics, Opioid; Chronic Pain; Cross-Cultural Comparison; Drug Overdose; Drug Prescriptions; Europe; Humans; Opioid-Related Disorders; Oxycodone; Pain Management; Practice Patterns, Physicians'; Rhode Island | 2020 |
Switching From High-Dose, Long-Term Opioids to Buprenorphine: A Case Series.
Topics: Analgesics, Opioid; Buprenorphine; Chronic Pain; Dose-Response Relationship, Drug; Drug Administration Schedule; Drug Substitution; Humans; Low Back Pain; Male; Middle Aged; Oxycodone | 2020 |
How I treat pain in hematologic malignancies safely with opioid therapy.
Topics: Abdominal Pain; Adult; Analgesics, Opioid; Anti-Inflammatory Agents, Non-Steroidal; Back Pain; Chronic Pain; Combined Modality Therapy; Disease Susceptibility; Drug Monitoring; Hematologic Neoplasms; Hostility; Humans; Leukemia, Myelogenous, Chronic, BCR-ABL Positive; Male; Middle Aged; Multiple Myeloma; Opioid-Related Disorders; Oxycodone; Pain Management; Patient Education as Topic; Phantom Limb; Physical Therapy Modalities; Risk Assessment; Stress Disorders, Post-Traumatic; Substance-Related Disorders; Thrombocythemia, Essential; Yoga | 2020 |
[Current status and issues in clinical use of opioids].
Topics: Analgesics, Opioid; Chronic Pain; Humans; Japan; Oxycodone | 2021 |
Evaluating the stability of opioid efficacy over 12 months in patients with chronic noncancer pain who initially demonstrate benefit from extended release oxycodone or hydrocodone: harmonization of Food and Drug Administration patient-level drug safety st
Topics: Analgesics, Opioid; Chronic Pain; Delayed-Action Preparations; Humans; Hydrocodone; Oxycodone; Pharmaceutical Preparations; United States; United States Food and Drug Administration | 2022 |
Effectiveness and Safety of Once-Daily Extended-Release Hydrocodone in Individuals Previously Receiving Immediate-Release Oxycodone for Chronic Pain.
Topics: Adult; Aged; Analgesia; Analgesics, Opioid; Chronic Pain; Delayed-Action Preparations; Drug Administration Schedule; Female; Humans; Hydrocodone; Male; Middle Aged; Oxycodone; Pain Management | 2018 |
Oral oxycodone/naloxone for pain control in cirrhosis: Observational study in patients with symptomatic metastatic hepatocellular carcinoma.
Topics: Administration, Oral; Aged; Aged, 80 and over; Analgesics, Opioid; Cancer Pain; Carcinoma, Hepatocellular; Chronic Pain; Delayed-Action Preparations; Drug Combinations; Female; Humans; Liver Cirrhosis; Liver Neoplasms; Male; Middle Aged; Naloxone; Narcotic Antagonists; Oxycodone; Preliminary Data; Quality of Life; Treatment Outcome | 2018 |
Comment on a paper by Dupoiron et al. "A phase III randomized controlled study on the efficacy and improved bowel function of prolonged-release (PR) oxycodone- naloxone (up to 160/80 mg daily) versus oxycodone PR".
Topics: Analgesics, Opioid; Chronic Pain; Delayed-Action Preparations; Drug Combinations; Naloxone; Narcotic Antagonists; Oxycodone | 2017 |
Assessment of Tapentadol API Abuse Liability With the Researched Abuse, Diversion and Addiction-Related Surveillance System.
Topics: Analgesics, Opioid; Chronic Pain; Female; Humans; Male; Opioid-Related Disorders; Oxycodone; Retrospective Studies; Substance-Related Disorders; Tapentadol | 2018 |
Trends and uptake of new formulations of controlled-release oxycodone in Canada.
Topics: Analgesics, Opioid; Canada; Chronic Pain; Cross-Sectional Studies; Delayed-Action Preparations; Drug Prescriptions; Drugs, Generic; Humans; Opioid-Related Disorders; Oxycodone; Pharmacies; Practice Patterns, Physicians' | 2018 |
The curse of relieving pain.
Topics: Acute Disease; Adult; Analgesics, Opioid; Back Pain; Chronic Pain; Compartment Syndromes; Drug Overdose; Fasciotomy; Female; Forearm; Hemangioma; Humans; Oxycodone; Spinal Neoplasms; Unconsciousness | 2018 |
Opioids for Acute Pain: Proceed with Caution.
Topics: Acetaminophen; Acute Pain; Adult; Analgesics, Opioid; Chronic Pain; Drug Combinations; Female; Fractures, Bone; Humans; Opioid-Related Disorders; Oxycodone; United States | 2018 |
Patterns of regional variation of opioid prescribing in primary care in England: a retrospective observational study.
Topics: Analgesics, Opioid; Buprenorphine; Chronic Pain; Crime; Databases, Factual; Education; Employment; England; Health Status; Housing; Humans; Income; Methadone; Morphine; Oxycodone; Practice Patterns, Physicians'; Primary Health Care; Residence Characteristics; Retrospective Studies; Socioeconomic Factors; Tramadol | 2018 |
Changes in consumption of opioid analgesics in Israel 2009 to 2016: An update focusing on oxycodone and fentanyl formulations.
Topics: Analgesics, Opioid; Chronic Pain; Databases, Factual; Dose-Response Relationship, Drug; Drug Combinations; Drug Prescriptions; Drug Utilization; Fentanyl; Humans; Israel; Opioid-Related Disorders; Oxycodone; Pharmacoepidemiology; Practice Patterns, Physicians' | 2018 |
Comparative out-of-hospital mortality of long-acting opioids prescribed for non-cancer pain: A retrospective cohort study.
Topics: Adult; Aged; Analgesics, Opioid; Chronic Pain; Delayed-Action Preparations; Drug Overdose; Female; Fentanyl; Follow-Up Studies; Humans; Male; Middle Aged; Morphine; Oxycodone; Retrospective Studies; Transdermal Patch | 2019 |
Prescription opioid analgesic use in France: Trends and impact on morbidity-mortality.
Topics: Adult; Aged; Analgesics, Opioid; Chronic Pain; Codeine; Databases, Factual; Dextropropoxyphene; Female; Fentanyl; France; Humans; Male; Middle Aged; Mortality; Opioid-Related Disorders; Opium; Oxycodone; Prevalence; Proportional Hazards Models; Tramadol | 2019 |
A Health Plan's Formulary Led To Reduced Use Of Extended-Release Opioids But Did Not Lower Overall Opioid Use.
Topics: Analgesics, Opioid; California; Chronic Pain; Drug Prescriptions; Female; Humans; Insurance, Health; Male; Middle Aged; Oxycodone; Practice Patterns, Physicians' | 2018 |
Increases in controlled-release oxycodone utilisation following the subsidy of oxycodone with naloxone formulations: An Australian population-based study.
Topics: Administration, Oral; Adult; Aged; Aged, 80 and over; Analgesics, Opioid; Australia; Chronic Pain; Delayed-Action Preparations; Dose-Response Relationship, Drug; Drug Combinations; Drug Utilization; Female; Humans; Interrupted Time Series Analysis; Male; Middle Aged; Naloxone; Narcotic Antagonists; Oxycodone; Practice Patterns, Physicians'; Retrospective Studies; Severity of Illness Index; Substance-Related Disorders | 2019 |
Abuse-Deterrent Opioids: The Authors Reply.
Topics: Analgesics, Opioid; Chronic Pain; Hepatitis C; Humans; Opioid-Related Disorders; Oxycodone | 2019 |
Outcomes Associated with Treatment of Chronic Pain with Tapentadol Compared with Morphine and Oxycodone: A UK Primary Care Observational Study.
Topics: Adult; Aged; Analgesics, Opioid; Chronic Pain; Delayed-Action Preparations; Female; Humans; Male; Middle Aged; Morphine; Oxycodone; Pain Management; Tapentadol; United Kingdom | 2019 |
Oxycodone, fentanyl, and morphine amplify established neuropathic pain in male rats.
Topics: Analgesics, Opioid; Animals; Chronic Pain; Disease Models, Animal; Fentanyl; Male; Morphine; Neuralgia; Oxycodone; Pain Measurement; Rats, Sprague-Dawley | 2019 |
Medical Use of Long-term Extended-release Opioid Analgesics in Commercially Insured Adults in the United States.
Topics: Adult; Aged; Analgesics, Opioid; Arthritis; Back Pain; Cancer Pain; Chronic Pain; Delayed-Action Preparations; Duration of Therapy; Female; Fentanyl; Humans; Insurance, Health; Male; Middle Aged; Morphine; Oxycodone; Tramadol; United States | 2020 |
Budget impact analysis of tapentadol extended release for the treatment of moderate to severe chronic noncancer pain.
Topics: Analgesics, Opioid; Budgets; Chronic Pain; Cost Savings; Costs and Cost Analysis; Delayed-Action Preparations; Formularies as Topic; Health Care Costs; Humans; Models, Economic; Oxycodone; Phenols; Severity of Illness Index; Tapentadol; United States | 2013 |
Buprenorphine/naloxone as a promising therapeutic option for opioid abusing patients with chronic pain: reduction of pain, opioid withdrawal symptoms, and abuse liability of oral oxycodone.
Topics: Administration, Oral; Adult; Analgesics, Opioid; Buprenorphine; Chronic Pain; Dose-Response Relationship, Drug; Female; Follow-Up Studies; Humans; Male; Middle Aged; Naloxone; Narcotic Antagonists; Opiate Substitution Treatment; Opioid-Related Disorders; Oxycodone; Statistics, Nonparametric | 2013 |
Rational prescribing.
Topics: Acetaminophen; Analgesics, Opioid; Chronic Pain; Drug Combinations; Humans; Long-Term Care; Minnesota; Opioid-Related Disorders; Oxycodone; Pain Measurement; Practice Patterns, Physicians'; Prescription Drug Misuse | 2013 |
G protein-gated inwardly rectifying potassium (KIR3) channels play a primary role in the antinociceptive effect of oxycodone, but not morphine, at supraspinal sites.
Topics: Animals; Brain; Chronic Pain; Disease Models, Animal; Dose-Response Relationship, Drug; G Protein-Coupled Inwardly-Rectifying Potassium Channels; Injections, Intraventricular; Injections, Spinal; Male; Mice; Mice, Inbred C3H; Mice, Inbred C57BL; Morphine; Narcotics; Neuralgia; Nociception; Oxycodone; Pain Measurement; Potassium Channel Blockers; RNA Interference; RNA, Small Interfering; Xenopus laevis | 2014 |
Only modest long-term opioid dose escalation occurs over time in chronic nonmalignant pain management.
Topics: Administration, Oral; Adolescent; Adult; Aged; Aged, 80 and over; Analgesics, Opioid; Chronic Pain; Cohort Studies; Databases, Factual; Delayed-Action Preparations; Dose-Response Relationship, Drug; Drug Tolerance; Female; Fentanyl; Humans; Longitudinal Studies; Male; Middle Aged; Morphine; Oxycodone; Retrospective Studies; Time Factors; Transdermal Patch; United Kingdom; Young Adult | 2013 |
Efficacy and gastrointestinal tolerability of oral oxycodone/naloxone combination for chronic pain in outpatients with cancer: an observational study.
Topics: Administration, Oral; Ambulatory Care; Analgesics, Opioid; Chronic Pain; Constipation; Drug Combinations; Female; Humans; Male; Middle Aged; Naloxone; Neoplasms; Oxycodone; Pain Management; Pain Measurement; Retrospective Studies; Treatment Outcome | 2014 |
Use of prescription opioids with abuse-deterrent technology to address opioid abuse.
Topics: Adolescent; Adult; Analgesics, Opioid; Chronic Pain; Delayed-Action Preparations; Female; Humans; Male; Middle Aged; Opioid-Related Disorders; Oxycodone; Oxymorphone; Patient Acceptance of Health Care; United States; Young Adult | 2014 |
Candidate metrics for evaluating the impact of prescriber education on the safe use of extended-release/long-acting (ER/LA) opioid analgesics.
Topics: Adult; Aged; Aged, 80 and over; Chronic Pain; Comorbidity; Delayed-Action Preparations; Dose-Response Relationship, Drug; Drug Monitoring; Drug Prescriptions; Drug Tolerance; Education, Medical, Continuing; Female; Humans; Inappropriate Prescribing; Kidney Failure, Chronic; Male; Medicare; Middle Aged; Narcotics; Oxycodone; Practice Guidelines as Topic; Practice Patterns, Physicians'; United States | 2014 |
Comparing tapentadol to oxycodone/naloxone combination: building castles in the air.
Topics: Chronic Pain; Humans; Musculoskeletal Pain; Naloxone; Oxycodone; Phenols | 2015 |
Comparing tapentadol to oxycodone/naloxone combination: imagining castles in the air … while building sandcastles! Re: Coluzzi F, Ruggeri M. Clinical and economic evaluation of tapentadol extended release and oxycodone/naloxone extended release in compari
Topics: Chronic Pain; Humans; Musculoskeletal Pain; Naloxone; Oxycodone; Phenols | 2015 |
Alcohol, pain, and opioids: which is a major threat to driving ability?
Topics: Acoustic Stimulation; Adult; Aged; Alcohol Drinking; Analgesics, Opioid; Automobile Driving; Chronic Pain; Drug Combinations; Humans; Middle Aged; Naloxone; Oxycodone; Photic Stimulation; Psychomotor Performance; Reflex | 2014 |
Efficacy and tolerability of low-dose oral prolonged-release oxycodone/naloxone for chronic nononcological pain in older patients.
Topics: Activities of Daily Living; Aged; Chronic Pain; Constipation; Delayed-Action Preparations; Dose-Response Relationship, Drug; Drug Combinations; Drug Monitoring; Female; Humans; Italy; Male; Naloxone; Oxycodone; Pain Management; Pain Measurement; Prospective Studies; Quality of Life; Treatment Outcome | 2015 |
Evaluation of an Extended-Release, Abuse-Deterrent, Microsphere-in-Capsule Analgesic for the Management of Patients with Chronic Pain With Dysphagia (CPD).
Topics: Adult; Analgesics, Opioid; Capsules; Chemistry, Pharmaceutical; Chronic Pain; Deglutition; Deglutition Disorders; Delayed-Action Preparations; Food; Humans; Intubation, Gastrointestinal; Microspheres; Opioid-Related Disorders; Oxycodone; Pain Management | 2016 |
Postoperative oxycodone toxicity in a patient with chronic pain and end-stage renal disease.
Topics: Administration, Oral; Adult; Analgesics; Biotransformation; Chronic Pain; Female; Humans; Infusions, Intravenous; Joint Capsule Release; Kidney Failure, Chronic; Leg; Naloxone; Narcotic Antagonists; Oxycodone; Pain, Postoperative; Renal Dialysis; Respiratory Insufficiency; Treatment Outcome | 2015 |
Treatment with prolonged-release oxycodone/naloxone improves pain relief and opioid-induced constipation compared with prolonged-release oxycodone in patients with chronic severe pain and laxative-refractory constipation.
Topics: Aged; Analgesics, Opioid; Chronic Pain; Constipation; Delayed-Action Preparations; Drug Combinations; Female; Humans; Laxatives; Male; Middle Aged; Naloxone; Oxycodone; Quality of Life | 2015 |
Effectiveness of opioid analgesics in chronic noncancer pain.
Topics: Adult; Aged; Analgesics, Opioid; Buprenorphine; Chronic Pain; Female; Fentanyl; Humans; Hydromorphone; Longitudinal Studies; Male; Middle Aged; Multivariate Analysis; Opioid-Related Disorders; Oxycodone; Pain Clinics; Pain Measurement; Personality; Phenols; Prospective Studies; Quality of Life; Surveys and Questionnaires; Tapentadol; Treatment Outcome | 2015 |
A 37-year-old man with chronic low back pain and substance abuse.
Topics: Adult; Alcohol-Related Disorders; Chronic Pain; Humans; Low Back Pain; Male; Opioid-Related Disorders; Oxycodone; Risk Factors | 2015 |
Efficacy and safety profile of prolonged release oxycodone in combination with naloxone (OXN PR) in Parkinson's disease patients with chronic pain.
Topics: Aged; Aged, 80 and over; Chronic Pain; Delayed-Action Preparations; Drug Combinations; Female; Humans; Male; Middle Aged; Naloxone; Oxycodone; Parkinson Disease; Prospective Studies; Quality of Life; Treatment Outcome | 2015 |
Evaluation of the tamper-resistant properties of biphasic immediate-release/extended-release oxycodone/acetaminophen tablets.
Topics: Acetaminophen; Acute Pain; Administration, Intranasal; Analgesics, Opioid; Chronic Pain; Delayed-Action Preparations; Drug Combinations; Drug Compounding; Humans; Opioid-Related Disorders; Oxycodone; Pain Management; Particle Size; Solubility; Solvents; Stress, Mechanical; Tablets | 2016 |
Is oxycodone/naloxone effective and safe in managing chronic pain of a fragile elderly patient with multiple skin ulcers of the lower limbs? A case report.
Topics: Aged, 80 and over; Analgesics, Opioid; Chronic Pain; Diabetes Complications; Drug Combinations; Female; Frail Elderly; Humans; Lower Extremity; Naloxone; Narcotic Antagonists; Oxycodone; Pain Management; Quality of Life; Skin Ulcer | 2015 |
Cost-effectiveness analysis of oxycodone with naloxone versus oxycodone alone for the management of moderate-to-severe pain in patients with opioid-induced constipation in Canada.
Topics: Adult; Analgesics, Opioid; Canada; Chronic Pain; Constipation; Cost-Benefit Analysis; Drug Combinations; Female; Humans; Male; Monte Carlo Method; Naloxone; Narcotic Antagonists; Oxycodone; Pain Management; Quality-Adjusted Life Years; Treatment Outcome | 2016 |
Efficacy and tolerability of oral oxycodone and oxycodone/naloxone combination in opioid-naïve cancer patients: a propensity analysis.
Topics: Aged; Analgesics, Opioid; Chronic Pain; Constipation; Defecation; Drug Combinations; Female; Humans; Laxatives; Male; Middle Aged; Naloxone; Narcotic Antagonists; Neoplasms; Oxycodone; Pain Measurement; Propensity Score; Quality of Life; Retrospective Studies; Rome; Severity of Illness Index; Surveys and Questionnaires; Time Factors; Treatment Outcome | 2015 |
On Doing the Right Thing.
Topics: Analgesics, Opioid; Chronic Pain; Humans; Oxycodone; Pain Management | 2016 |
Pain Rules Are a Pain for Doctors.
Topics: Analgesics, Opioid; Chronic Pain; Diazepam; Drug and Narcotic Control; Drug Prescriptions; Humans; Oxycodone; Physicians; Texas | 2016 |
[Dual effect prevents chronic course].
Topics: Chronic Pain; Delayed-Action Preparations; Drug Combinations; Humans; Naloxone; Oxycodone; Phenols; Tapentadol | 2015 |
Effectiveness and safety of oxycodone/naloxone in the management of chronic pain in patients with systemic sclerosis with recurrent digital ulcers: two case reports.
Topics: Administration, Oral; Aged; Analgesics, Opioid; Chronic Pain; Drug Therapy, Combination; Female; Fingers; Humans; Middle Aged; Naloxone; Oxycodone; Pain Management; Quality of Life; Scleroderma, Systemic; Skin Ulcer; Wound Healing | 2016 |
Long-term efficacy and safety of oxycodone-naloxone prolonged release in geriatric patients with moderate-to-severe chronic noncancer pain: a 52-week open-label extension phase study.
Topics: Aged; Aged, 80 and over; Analgesics; Chronic Pain; Delayed-Action Preparations; Drug Combinations; Female; Humans; Male; Naloxone; Oxycodone; Prospective Studies; Safety; Time Factors | 2016 |
FDA Approval of Extended-Release Oxycodone for Children With Severe Pain.
Topics: Adolescent; Analgesics, Opioid; Child; Chronic Pain; Delayed-Action Preparations; Drug Approval; Humans; Opioid-Related Disorders; Oxycodone; Severity of Illness Index; United States; United States Food and Drug Administration | 2016 |
Switching to low-dose oral prolonged-release oxycodone/naloxone from WHO-Step I drugs in elderly patients with chronic pain at high risk of early opioid discontinuation.
Topics: Aged; Aged, 80 and over; Analgesics, Opioid; Chronic Pain; Constipation; Delayed-Action Preparations; Drug Combinations; Female; Humans; Italy; Male; Naloxone; Oxycodone; Pain Measurement; Quality of Life; Retrospective Studies; Severity of Illness Index | 2016 |
Prescription of Long-Acting Opioids and Mortality in Patients With Chronic Noncancer Pain.
Topics: Analgesics, Opioid; Anticonvulsants; Antidepressive Agents; Cardiovascular Diseases; Cause of Death; Chronic Pain; Drug Overdose; Drug Prescriptions; Female; Fentanyl; Humans; Male; Methadone; Middle Aged; Morphine; Oxycodone; Propensity Score; Proportional Hazards Models; Retrospective Studies; Risk | 2016 |
New Initiation of Long-Acting Opioids in Long-Stay Nursing Home Residents.
Topics: Administration, Cutaneous; Aged; Aged, 80 and over; Analgesics, Opioid; Buprenorphine; Chronic Pain; Delayed-Action Preparations; Dose-Response Relationship, Drug; Drug Utilization; Female; Fentanyl; Homes for the Aged; Humans; Long-Term Care; Male; Morphine; Nursing Homes; Oxycodone; Oxymorphone; Practice Patterns, Physicians'; Rhode Island; Tramadol | 2016 |
Association Between Commonly Prescribed Opioids and Androgen Deficiency in Men: A Retrospective Cohort Analysis.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Analgesics, Opioid; California; Chronic Pain; Cohort Studies; Comorbidity; Drug Prescriptions; Drug-Related Side Effects and Adverse Reactions; Humans; Male; Men's Health; Middle Aged; Oxycodone; Prescription Drugs; Prevalence; Retrospective Studies; Risk Factors; Testosterone; Treatment Outcome; Young Adult | 2017 |
Understanding opioid overdose characteristics involving prescription and illicit opioids: A mixed methods analysis.
Topics: Adult; Analgesics, Opioid; Benzodiazepines; Chronic Pain; Drug Overdose; Female; Humans; Male; Oxycodone; Pain Management; Prescription Drug Misuse; Prescriptions; Risk Factors; Social Support; Substance-Related Disorders | 2016 |
Predictive Value of Positive Drug Screening Results in an Urban Outpatient Population.
Topics: Amphetamines; Analgesics, Opioid; Barbiturates; Benzodiazepines; Cannabinoids; Chronic Pain; Cocaine; Drug Evaluation, Preclinical; Gas Chromatography-Mass Spectrometry; Humans; Immunoassay; Methadone; Opiate Alkaloids; Oxycodone; Prospective Studies; Tandem Mass Spectrometry | 2016 |
Dialyzability of Oxycodone and Its Metabolites in Chronic Noncancer Pain Patients with End-Stage Renal Disease.
Topics: Adult; Analgesics, Opioid; Chronic Disease; Chronic Pain; Female; Humans; Kidney Failure, Chronic; Male; Middle Aged; Morphinans; Oxycodone; Oxymorphone; Renal Dialysis | 2017 |
Impact of breakthrough pain on community-dwelling cancer patients: results from the National Breakthrough Pain Study.
Topics: Adolescent; Adult; Aged; Analgesics, Opioid; Breakthrough Pain; Chronic Pain; Cross-Sectional Studies; Female; Health Surveys; Humans; Hydrocodone; Independent Living; Male; Middle Aged; Neoplasms; Oxycodone; Pain Measurement; Quality of Life; Surveys and Questionnaires; United States | 2017 |
Ultra-High-Dose Opioids With Low Efficacy and Significant Harm-Time to Make a Change: A Teachable Moment.
Topics: Analgesics, Opioid; Back Pain; Chronic Pain; Dose-Response Relationship, Drug; Female; Health Behavior; Humans; Middle Aged; Motivation; Oxycodone | 2017 |
RGS9-2 Modulates Responses to Oxycodone in Pain-Free and Chronic Pain States.
Topics: Analgesics, Opioid; Animals; Chronic Pain; Dose-Response Relationship, Drug; Male; Mice; Mice, Inbred C57BL; Mice, Knockout; Oxycodone; Pain Measurement; RGS Proteins; Treatment Outcome | 2017 |
Treatment of Prescription Opioid Use Disorder in Pregnant Women.
Topics: Adult; Analgesics, Opioid; Chronic Pain; Cognitive Behavioral Therapy; Female; Humans; Opioid-Related Disorders; Oxycodone; Pregnancy; Pregnancy Complications; Treatment Outcome | 2017 |
Perceptions of Community-Dwelling Patients and Their Physicians on OxyContin® Discontinuation and the Impact on Chronic Pain Management.
Topics: Aged; Analgesics, Opioid; Canada; Chronic Pain; Continuity of Patient Care; Female; Humans; Independent Living; Male; Middle Aged; Motivation; Oxycodone; Pain Management; Pain Measurement; Patient Satisfaction; Perception; Physicians | 2017 |
Interaction of oxycodone and voriconazole-a case series of patients with cancer pain supports the findings of randomised controlled studies with healthy subjects.
Topics: Analgesics, Opioid; Antifungal Agents; Aspergillosis; Burkitt Lymphoma; Chronic Pain; Female; Humans; Male; Oxycodone; Pyrimidines; Triazoles; Voriconazole | 2011 |
Effects of voriconazole co-administration on oxycodone-induced adverse events: a case in the retrospective survey.
Topics: Adult; Aged; Aged, 80 and over; Analgesics, Opioid; Antifungal Agents; Aspergillosis; Burkitt Lymphoma; Chronic Pain; Cytochrome P-450 CYP3A; Cytochrome P-450 CYP3A Inhibitors; Drug Interactions; Enzyme Inhibitors; Female; Humans; Male; Middle Aged; Mycoses; Oxycodone; Pyrimidines; Receptors, Opioid, mu; Retrospective Studies; Triazoles; Voriconazole | 2011 |
Effect of tapentadol extended release on productivity: results from an analysis combining evidence from multiple sources.
Topics: Adult; Aged; Chronic Pain; Cohort Studies; Constipation; Cross-Sectional Studies; Delayed-Action Preparations; Double-Blind Method; Efficiency; Female; Humans; Male; Markov Chains; Middle Aged; Narcotics; Oxycodone; Phenols; Randomized Controlled Trials as Topic; Retrospective Studies; Surveys and Questionnaires; Tapentadol | 2012 |
Do CYP2D6 genotypes reflect oxycodone requirements for cancer patients treated for cancer pain? A cross-sectional multicentre study.
Topics: Adult; Aged; Aged, 80 and over; Analgesics, Opioid; Biotransformation; Chronic Pain; Cohort Studies; Cross-Sectional Studies; Cytochrome P-450 CYP2D6; Cytochrome P-450 CYP2D6 Inhibitors; Drug Monitoring; Europe; Female; Genetic Association Studies; Humans; Male; Middle Aged; Morphinans; Neoplasms; Oxycodone; Oxymorphone; Polymorphism, Genetic; Severity of Illness Index | 2012 |
Canadian guideline for safe and effective use of opioids for chronic noncancer pain: clinical summary for family physicians. Part 1: general population.
Topics: Analgesics, Opioid; Benzodiazepines; Canada; Chronic Pain; Codeine; Humans; Hydromorphone; Mass Screening; Opioid-Related Disorders; Oxycodone; Patient Education as Topic; Sleep Apnea Syndromes; Tramadol | 2011 |
Characteristics of chronic pain patients in a rural teaching practice.
Topics: Adult; Aged; Alcohol-Related Disorders; Analgesics, Opioid; Back Pain; Chronic Pain; Female; Health Status; Humans; Male; Middle Aged; Musculoskeletal Pain; Office Visits; Ontario; Opioid-Related Disorders; Oxycodone; Primary Health Care; Retrospective Studies; Rural Health Services; Tobacco Use Disorder | 2011 |
Pharmacists' experiences with dispensing opioids: provincial survey.
Topics: Adult; Aged; Alcohol Drinking; Analgesics, Opioid; Chronic Pain; Codeine; Data Collection; Drug Prescriptions; Drug-Seeking Behavior; Female; Health Knowledge, Attitudes, Practice; Humans; Hydromorphone; Hypnotics and Sedatives; Interdisciplinary Communication; Interprofessional Relations; Male; Medication Adherence; Middle Aged; Ontario; Oxycodone; Pharmacists; Practice Patterns, Physicians' | 2011 |
Clearing the smoke around medical marijuana.
Topics: Analgesics, Opioid; Chronic Pain; Dronabinol; Female; Humans; Male; Morphine; Oxycodone | 2011 |
Prolonged-release oxycodone/naloxone in the treatment of neuropathic pain - results from a large observational study.
Topics: Aged; Analgesics, Opioid; Chronic Pain; Constipation; Defecation; Delayed-Action Preparations; Drug Combinations; Female; Germany; Humans; Male; Middle Aged; Naloxone; Narcotic Antagonists; Neuralgia; Oxycodone; Pain Measurement; Prospective Studies; Quality of Life; Severity of Illness Index; Time Factors; Treatment Outcome | 2012 |
Cost-effectiveness of tapentadol prolonged release compared with oxycodone controlled release in the UK in patients with severe non-malignant chronic pain who failed 1st line treatment with morphine.
Topics: Analgesics, Opioid; Chronic Pain; Cost-Benefit Analysis; Delayed-Action Preparations; Humans; Markov Chains; Morphine; Oxycodone; Phenols; Quality-Adjusted Life Years; Retrospective Studies; Severity of Illness Index; State Medicine; Surveys and Questionnaires; Tapentadol; United Kingdom | 2012 |
The role of cannabinoids in chronic pain patients remains hazy.
Topics: Analgesics, Opioid; Chronic Pain; Dronabinol; Female; Humans; Male; Morphine; Oxycodone | 2012 |
Nepenthe.
Topics: Adult; Analgesics, Opioid; Attitude of Health Personnel; Chronic Pain; Drug Overdose; Humans; Male; Opioid-Related Disorders; Oxycodone | 2012 |
Unpredictable absorption of oral opioid medications in a quadriplegic patient with chronic enterocutaneous fistulas.
Topics: Administration, Oral; Analgesics, Opioid; Benzodiazepines; Biological Availability; Chronic Disease; Chronic Pain; Humans; Intestinal Fistula; Male; Methadone; Morphine; Oxycodone; Quadriplegia; Young Adult | 2012 |
The implications of tamper-resistant formulations for opioid rotation.
Topics: Analgesics, Opioid; Chronic Pain; Delayed-Action Preparations; Drug Combinations; Drug Compounding; Drug Tolerance; Humans; Morphine; Naltrexone; Opioid-Related Disorders; Oxycodone; Oxymorphone; Patient Selection | 2012 |
Economic study on the impact of side effects in patients taking oxycodone controlled-release for noncancer pain.
Topics: Administration, Oral; Adult; Analgesics, Opioid; Chronic Pain; Data Collection; Delayed-Action Preparations; Dose-Response Relationship, Drug; Female; Health Care Costs; Humans; Insurance, Health, Reimbursement; Male; Medicare; Middle Aged; Neuralgia; Oxycodone; United States | 2012 |
Clinical simulation model of long-acting opioids for treatment of chronic non-cancer pain in the United States.
Topics: Analgesics, Opioid; Chronic Pain; Computer Simulation; Costs and Cost Analysis; Delayed-Action Preparations; Dose-Response Relationship, Drug; Health Expenditures; Humans; Monte Carlo Method; Outcome Assessment, Health Care; Oxycodone; Phenols; Tapentadol; United States | 2013 |
Prolonged-release oxycodone/naloxone in nonmalignant pain: single-center study in patients with constipation.
Topics: Adult; Aged; Aged, 80 and over; Analgesics, Opioid; Chronic Pain; Constipation; Delayed-Action Preparations; Drug Combinations; Female; Humans; Male; Middle Aged; Naloxone; Oxycodone; Pain Measurement; Retrospective Studies; Treatment Outcome | 2013 |